CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene

Author： Skierka Jennifer M Walker Denise L Peterson Sandra E O’Kane Dennis J Black John Logan

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.8, 2012-06, pp. : 951-954

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Implementation of CYP2D6 genotyping in psychiatry

By Loovers Harriët M van der Weide Jan

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1065-1077

Informa Healthcare

Access to resources Recommend Favorite

Use of CYP2D6 genotyping in practice: tamoxifen dose adjustment

By Walko Christine M McLeod Howard

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 691-697

Future Medicine

Access to resources Recommend Favorite

Copy number variation and gene rearrangements in CYP2D6 genotyping using multiplex ligation-dependent probe amplification in Koreans

By Kim Juwon Lee Soo-Youn Lee Kyung-A

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 963-973

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetic Screening of the Gene Deletion and Duplications of CYP2D6

By Meijerman Irma Sanderson Linda Smits Paul Beijnen Jos Schellens Jan

Drug Metabolism Reviews, Vol. 39, Iss. 1, 2007-01 ,pp. : 45-60

Informa Healthcare

Access to resources Recommend Favorite

Allelic Variations in CYP2D6 Gene and Susceptibility to Cervical Cancer

Drug Metabolism Letters, Vol. 1, Iss. 4, 2007-12 ,pp. : 276-280

Bentham Science Publishers

Access to resources Recommend Favorite